Abstract:The issues of therapy response criteria, first-line hydroxy-carbamide intolerance and resistance to it as well as early changes in treatment strategy remain controversial and debatable in the management of polycythemia vera patients. The review outlines the results of literature data analysis related to the estimation of first-line therapy efficacy, it considers the spectrum and frequency of adverse events of hydroxycarbamide treatment, and focuses on the experience of using ruxolitinib, JAK2 inhibitor. The re… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.